Cannabinoids and chronic pelvic pain in women: Focus on endometriosis. Issue 3 (September 2021)

• Record Type: Journal Article
• Authors: Marcu, Ioana; Gee, Amy; Lynn, Becky
• Is Part Of: Journal of endometriosis and pelvic pain disorders. Volume 13:Issue 3(2021)
• Page Start: 155
• Page End: 165
• Publication Date: 2021-09
• Subjects: Cannabinoids -- marijuana -- THC -- CBD -- pelvic pain -- endometriosis -- interstitial cystitis -- bladder pain syndrome -- vulvodynia; Endometriosis -- Periodicals; Pelvic pain -- Periodicals; 618.1
• DOI: 10.1177/22840265211011277
• Languages: English
• ISSNs: 2284-0265

Abstract

Chronic pelvic pain in women is common and frequently difficult to treat. Chronic pelvic pain often develops in the setting of endometriosis, interstitial cystitis/bladder pain syndrome, and vulvodynia. Cannabinoids are a promising treatment modality for non-cancer chronic pain, but have not been studied in women with chronic pelvic pain nor in specific chronic pelvic pain conditions. This review focuses on the interaction of the endocannabinoid system with the menstrual cycles, with endometriotic lesions, and within the bladder. Furthermore, it provides a brief overview of existing literature of the effects of endocannabinoids on chronic pain generally, with a focus on neuropathic pain. Finally, it discusses limited data available regarding the use of cannabinoids in women with chronic pelvic pain conditions. In the opinion of the authors, cannabinoids are a reasonable treatment modality for refractory chronic pelvic pain, especially if a neuropathic component is suspected. Practitioners should expect a modest effect on pain levels with an acceptable safety profile.